From the Centers for Disease Control: Asthma -United States, 1980-1990. JAMA.1992;268(15):1995, 1999.
2.
National Asthma Education and Prevention Program Expert Panel Report II. Guidelines for the diagnosis and management of asthma. National Institutes of Health.1997.
3.
American Association for Respiratory Care. Aerosol Consensus State-ment -1991. Respir Care.1991;36(9):916–921.
4.
TurnerMO, GafnieA, SwanD, FitzGeraldJM. A review and eco-nomic evaluation of bronchodilator delivery methods in hospitalized patients. Arch Intern Med.1996;156(18):2113–2118.
5.
JasperAC, MohsenifarZ, KahanS, GoldbergHS, KoernerSK. Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients. Chest.1987;91(4):614–618.
6.
SummerW, ElstonR, TharpeL, NelsonS, HaponikEF. Aerosol bronchodilator delivery METHODS: relative impact on pulmonary func-tion and cost of respiratory care. Arch Intern Med.1989;149(3):618–623.
7.
O'ReillyJF, BuchananDR, SudlowMF. Pressurised arosol with conical spacer is an effective alternative to nebuliser in chronic sta-ble asthma. Br Med J (Clin Res Ed).1983;286(6377):1548.
8.
GervaisA, BeginP.Bronchodilatation with a metered-dose inhaler plus an extension, using tidal breathing vs jet nebulization. Chest.1987;92(5):822–824.
9.
TaralaRA, MadsenBW, PattersonJW. Comparative efficacy of salbutamol by pressurized aerosol and wet nebulizer in acute asthma. Br J Clin Pharmacol.1980;10(4):393–397.
10.
BowtonDL, GoldsmithWM, HaponickEF. Substitution of metered-dose inhalers for hand-held nebulizers: success and cost savings in a large, acute-care hospital. Chest.1992;101(2):305–308.
11.
NewhouseMT, DolovichM.Aerosol therapy: nebulizer vs metered dose inhaler. Chest.1987;91(6):799–800.
12.
TurnerMO, PatelA, GinsburgS, FitzGeraldJM. Bronchodilator delivery in acute airflow obstruction: a meta-analysis. Arch Intern Med.1997;157(15):1736–1744.
13.
ConnollyMJ. Inhaler technique of elderly patients: comparison of metered-dose inhalers and large volume spacer devices. Age Ageing.1995;24(3):190–192.
14.
NewmanSP. Aerosol generators and delivery systems. Respir Care.1991;36(9):939–951.
15.
FinkJB, DhandR, GrychowskiJ, FaheyPJ, TobinMJ. Reconciling in vitro and in vivo measurements of aerosol delivery from a metered-dose inahler during mechanical ventilation and defining efficiency-en-hancing factors. Am J Respir Crit Care Med.1999;159(1):63–68.
16.
NewmanSP, PaviaD, MorenF, SheahanNF, ClarkeSW. Deposi-tion of pressurised aerosols in the human respiratory tract. Thorax.1981;36:52–55.
17.
DolovichM, RuffinRE, RobertsR, NewhouseMT. Optimal deliv-ery of aerosols from metered dose inhalers. Chest.1981;80(6 Suppl):911–915.
18.
NewmanSP. A comparison of lung deposition patterns between different asthma inhalers (review). J Aerosol Med.1995;8 Suppl 3:S21–S26; discussion S27.
19.
LarsenJS, HahnM, EkholmB, WickKA. Evaluation of conven-tional press-and-breathe metered-dose inhaler technique in 501 pa-tients. J Asthma.1994;31(3):193–199.
20.
GuidryGG, BrownWD, StognerSW, GeorgeRB. Incorrect use of metered dose inhalers by medical personnel. Chest.1992;101(1):31–33.
21.
NewmanSP, PaviaD, ClarkeSW. Simple instructions for using pressurized aerosol bronchodilators. J R Soc Med.1980;73(11):776–779.
22.
De BlaquiereP, ChristensenDB, CarterWB, MartinTR. Use and misuse of metered-dose inhalers by patients with chronic lung dis-ease: a controlled, randomized trial of two instruction methods. Am Rev Respir Dis.1989;140(4):910–916.
23.
KraemerR, FreyU, SommerCW, RussiE.Short-term effect of albuterol, delivered via a new auxiliary device, in wheezy infants. Am Rev Respir Dis.1991;144(2):347–351.
24.
HodgesIGC, MilnerAD, StokesGM. Assessment of a new device for delivering aerosol drugs to asthmatic children. Arch Dis Child.1981;56(10):787–789.
25.
LeeH, EvansHE. Evaluation of inhalation aids of metered dose inhalers in asthmatic children. Chest.1987;91(3):366–369.
26.
GurwitzD, LevisonH, MindorffC, ReillyP, WorsleyG.Assess-ment of a new device (aerochamber) for use with aerosol drugs in asthmatic children. Ann Allergy.1983;50:166–170.
27.
BarberaJM, SlyRM, EbyDM, MiddletonHB. Responses to a bronchodilator aerosol delivered by Aerochamber to young children (abstract). Ann Allergy.1984;52(3 Pt 2):224.
28.
KatzR, RachelefskyG, RohrA, et al. Use of tube spacer. Aero-chamber (A) to improve the efficacy of a metered dose inhaler (MDI) in asthmatic children (abstract). J Allergy Clin Immunol.1986;77(1 Pt 2):185.
29.
KonigP, GayerD, KantakA, KreutzC, DouglassB, HordvikNL. A trial of metaproterenol by metered-dose inhaler and two spacers in preschool asthmatics. Pediatr Pulmonol.1988;5(4):247–251.
30.
ConnerWT, DolovichMB, FrameRA, NewhouseMT. Reliable salbutamol administration in 6-to 36-month-old children by means of a metered dose inhaler and Aerochamber with mask. Pediatr Pulmo-nol.1989;6(4):263–267.
31.
HessD, HorneyD, SnyderT.Medication-delivery performance of eight small-volume, hand-held nebulizers: effects of diluent volume, gas flowrate, and nebulizer model. Respir Care.1989;34(8):717–723.
32.
HessD, FisherD, WilliamsP, PoolerS, KacmarekRM. Medication nebulizer performance: effects of diluent volume, nebulizer flow, and nebulizer brand. Chest.1996;110(2):498–505.
33.
JohnsonMA, NewmanSP, BloomR, TalaceN, ClarkeSW. Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma: efficacy and pulmonary deposition. Chest.1989;96(1):6–10.
34.
AlvineGF, RodgersP, FitzsimmonsKM, AhrensRC. Disposable jet nebulizers: how reliable are they?Chest.1992;101(2):316–319.
LewisRA, FlemingJS. Fractional deposition from a jet nebulizer: how it differs from a metered dose inhaler. Br J Dis Chest.1985;79(4):361–367.
37.
LipworthBJ, ClarkRA, DhillonDP, BrownRA, McDevittDG. Beta-adrenoreceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma. Br J Clin Pharmacol.1988;26(5):527–533.
38.
SalzmanGA, SteeleMT, PribbleJP, ElenbaasRM, PyszczynskiDR. Aerosolized metaproterenol in the treatment of asthmatics with se-vere airflow obstruction: comparison of two delivery methods. Chest.1989;95(5):1017–1020.
39.
ColaconeA, AfilaloM, WolkoveN, KreismanH.A comparison of albuterol administered by metered dose inhaler (and holding cham-ber) or wet nebulizer in acute asthma. Chest.1993;104(3):835–841.
40.
IdrisAH, McDermottMF, RaucciJC, MorrabelA, McGorrayS, HendelesL.Emergency department treatment of severe asthma: me-tered-dose inhaler plus holding chamber is equivalent in effective-ness to nebulizer. Chest.1993;103(3):665–672.
41.
RodrigoG, RodrigoC.Comparison of salbutamol delivered by neb-ulizer or metered-dose inhaler with a pear-shaped spacer in acute asthma. Current Therapeutic Research. Clinical & Experimental.1993;54(6):797–808. 1993;93(6):800–808.
42.
RodrigoC, RodrigoG.Salbutamol treatment of acute severe asthma in the ED: MDI versus hand-held nebulizer. Am J Emerg Med.1998;16(7):637–642.
43.
RobertsonD.Dose-response study of albuterol by inhaler or nebu-lizer for acute asthma. Drug Therapeutics.1994;24(1):40.
44.
TurnerJR, CorkeryKJ, EckmanD, GelbAM, LipavskyA, SheppardD.Equivalence of continuous flow nebulizer and metered-dose in-haler with reservoir bag for treatment of acute airflow obstruction. Chest.1988;93(3):476–481.
45.
LevittMA, GambrioliEF, FinkJB. Comparative trial of continuous nebulization versus metered-dose inhaler in the treatment of acute bronchospasm. Ann Emerg Med.1995;26(3):273–277.
46.
MandelbergA, ChenE, NoviskiN, PrielIE. Nebulized wet aerosol treatment in emergency department-is it essential? comparison with large spacer device for metered-dose inhaler. Chest.1997;112(6):1501–1505.
47.
FuglsangG, PedersenS.Comparison of Nebuhaler and nebulizer treatment of acute severe asthma in children. Eur J Respir Dis.1986;69(2):109–113.
48.
KeremE, LevisonH, SchuhS, O'BrodovichH, ReismanJ, BenturL, CannyGJ. Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr.1993;123(2):313–317.
49.
LinYZ, HsiehKH. Metered dose inhaler and nebulizer in acute asthma. Arch Dis Child.1995;72(3):214–218.
50.
ParkinPC, SaundersNR, DiamondSA, WindersPM, MacarthurC.Randomised trial spacer v nebuliser for acute asthma. Arch Dis Child.1995;72(3):239–240.
51.
ChouKJ, CunninghamSJ, CrainEF. Metered-dose inhalers with spacers vs nebulizers for pediatric asthma. Arch Pediatr Adolesc Med.1995;149(2):201–205.
52.
WilliamsJR, BothnerJP, SwantonRD. Delivery of albuterol in a pediatric emergency department. Pediatre Emerg Care.1996;12(4):263–267.
53.
BatraV, SethiGR, SachdevHP. Comparative efficacy of jet nebu-lizer and metered dose inhaler with spacer device in the treatment of acute asthma. Indian Pediatr.1997;34(6):497–503.
54.
RobertsonCF, NordenMA, FitzgeraldDA, ConnorFL, Van As-perenPP, CooperPJ, et al. Treatment of acute asthma: salbutamol via jet nebuliser vs spacer and metered dose inhaler. J Paediatr Child Health.1998;34(2):142–146.
55.
BarryPW, O'CallaghanC.Multiple actuations of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range. Eur Respir J.1994;7(9):1707–1709.
56.
JamesRW, MastersIB. Single breath versus panting technique in salbutamol delivery through a 750 ml. spacing device. Pediatr Pul-monol.1990;8(4):263–267.
57.
ClosaRM, CeballosJM, Gomez-PapiA, GalianaAS, GutierrezC, Marti-HenneberC.Efficacy of bronchodilators adminstered by nebu-lizers versus spacer devices in infants with acute wheezing. Pediatr Pulmonol.1998;26(5):344–348.
58.
SchuhS, JohnsonDW, StephensD, CallahanS, WindersP, CannyGJ. Comparison of albuterol delivered by a metered dose inhaler with spacer versus a nebulizer in children with mild acute asthma. J Pediatr.1999;135(1):22–27.
59.
KuhlDA, AgiriOA, MauroLS. Beta-agonists in the treatment of acute exacerbation of chronic obstructive pulmonary disease (re-view). Ann Pharmacother.1994;28(12):1379–1388.
60.
CatesCJ. Holding chambers versus nebulisers for beta-agonist treat-ment of acute asthma (Cochrane Review). In: The Cochrane Library.Issue 1.1999. Oxford: Update Software.
SearsMR. Comparison of conventional and ultrasonic nebulization of bronchodilator drugs in asthmatic subjects. NZ Med J.1983;96(743 Pt 2):927–929.
63.
OlivensteinR, WollkoveN, CohenC, FrankH, KreismanH.A comparison of responses to albuterol delivered by two aerosol de-vices. Chest.1986;90(3):392–395.
64.
BallardRD, BoginRM, PakJ.Assessment of bronchodilator re-sponse to a beta-adrenergic delivered from an ultrasonic nebulizer. Chest.1991;100(2):410–415.
65.
NakanishiAK, LambBM, FosterC, RubinBK. Ultrasonic nebuli-zation of albuterol is no more effective than jet nebulization for the treatment of acute asthma in children. Chest.1997;111(6):1505–1508.
66.
TimsinaMP, MartinGP, Van der KolkH, TushulzenE, EnthobenR.The effect of inhalation flow on the performance of a dry powder inhalation system. Int J Pharm.1992;81:199–203.
67.
TimsinaMP, MartinGP, MarriottC, GandertonD, YainneskisM.Drug delivery to the respiratory tract using dry powder inhalers. Int J Pharm.1994;101:1–13.
68.
HindleM, ByronPR. Dose emissions from marketed dry powder inhalers. Int J Pharm.1995;116:169–177.
69.
KimCS, GarciaL.Delivery characteristics of albuterol powder aero-sol by rotahaler. J Aerosol Med.1993;6:199–211.
70.
HillLS, SlaterAL. A comparison of the performance of two modern multidose dry powder asthma inhalers. Respir Med.1998;92(1):105–110.
71.
BisgaardH, IfversenM, KlugB, StamstrupK, SumbyB.Inspiratory flow rate through the Diskus/Accuhaler inhaler and Turbuhaler inhaler in children with asthma (abstract). J Aerosol Med.1995;8:100 (P26).
72.
RomanR, MontealegreF, TarratsH, Fernandez CabreroA.A com-parison of albuterol solution nebulized versus albuterol powder given by breath activated metered dose inhaler. Bol Asoc Med PR.1993;85(1-3):12–15.
73.
RaimondiAC, SchottlenderJ, LombardiD, MolfinoNA. Treatment of acute severe asthma with inhaled albuterol delivered via jet neb-ulizer, metered dose inhaler with spacer, or dry powder. Chest.1997;112(1):24–28.
74.
TonnesenF, LaursenLC, EvaldT, StahlE, IbsenTB. Bronchodi-lating effect of terbutaline powder in acute severe bronchial obstruc-tion. Chest.1994;105(3):697–700.
75.
NanaA, YoungchaiyudP, MaranetraN, BoeJ, LofdahlCG, SelroosO, StahlE.B-agonists administered by a dry powder inhaler can be used in acute asthma. Respir Med.1998;9(2):167–172.
76.
SoleD, RizzoMCFV, PimentelAF, SanoF, BarretoBA, WandalsenNF, NaspitzCK. Effect of inhaled terbutaline sulphate (dry powder, Turbuhaler(TM) and nebulizer solution) in children with acute asthma. Journal of Pediatrics.1995;71(2):82–87. [Article in Portuguese].
77.
RufinP, BenoistMR, PanquevaP, BrouardJJ, De BlicJ, Schein-mannP.[Efficacy of a powder inhaler (Turbuhaler) in moderate asthmatic crises in children]. Rev Mal Respir.1993;10(6):545–550.
78.
RugginsNR, MilnerAD, SwarbrickA.An assessment of a new breath actuated inhaler device in acutely wheezy children. Arch Dis Child.1993;68(4):477–480.
79.
LipworthBJ, ClarkDJ. Lung delivery of salbutamol given by breath activated pressurized aerosol and dry powder inhaler devices. Pulm Pharmacol Ther.1997;10(4):211–214.
80.
SilvermanR, SellersJ, GreeneS, FlasterE, ColiceG.Comparison of the Maxair Autohaler to wet nebulizer in patients with acute asthma. Chest.1998;114(3):766–770.
81.
DolovichMB, KillianD, WolffRK, ObminskiG, NewhouseMT. Pulmonary aerosol deposition in chronic bronchitis: intermittent pos-itive pressure breathing vs quiet breathing. Am Rev Respir Dis.1977;115(3):397–402.
82.
The Intermittent Positive Pressure Breathing Trial Group. Intermit-tent positive pressure breathing therapy of chronic obstructive pul-monary disease: a clinical trial. Arch Intern Med.1983;99(5):612–620.
83.
LorenM, ChaiH, MiklichD, BarwiseG.Comparison between sim-ple nebulization and intermittent positive-pressure ventilation in asth-matic children with severe bronchospasm. Chest.1977;72(2):145–147.
84.
LowenthalD, KattanM.Facemasks versus mouthpieces for aerosol treatment of asthmatic children. Pediatr Pulmonol.1992;14(3):192–196.
85.
MartinJG, ShoreS, EngelLA. Effect of continuous postitive airway pressure on respiratory mechanics and pattern of breathing in in-duced asthma. Am Rev Respir Dis.1982;126(5):812–817.
86.
WangCH, LinHC, HuangTJ, YanCT, YuCT, KuoHP. Differential effects of nasal continuous positive airway pressure on reversible or fixed upper and lower airway obstruction. Eur Respir J.1996;9(5):952–959.
87.
ParkesSN, BerstenAD. Aerosol kinetics and bronchodilator effi-cacy during continuous positive airway pressure delivered by face mask. Thorax.1997;52(2):171–175.
88.
Frischknecht-ChristensenE, NorregaardO, DahlR.Treatment of bronchial asthma with terbutaline inhaled by conespacer combined with positive expiratory pressure mask. Chest.1991;100(2):317–321.
89.
PollackCVJr., FleischKB, DowseyK.Treatment of acute broncho-spasm with beta-adrenergic agonist aerosols delivered by a nasal bilevel positive airway pressure circuit. Ann Emerg Med.1995;26(5):552–557.
90.
O'DonohueWJJr.. Guidelines for the use of nebulizers in the home and at domicillary sites: report of a consensus conference (review). NAMDRC Consensus Group. Chest.1996;109(3):814–820.
HananiaNA, WittmanR, KestenS, ChapmanKR. Medical person-nel's knowledge of and ability to use inhaling devices: metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest.1994;105(1):111–116.
93.
FinkJB, DhandR.Aerosol therapy In: FinkJB, HuntJ editors. Clinical practice in respiratory care.Philadelphia: Raven-Lippincott;1998.